Opioid legislation stalls in Senate following House approval of bills in June

-
BlogAs the November midterm elections draw closer, the U.S. Senate is increasingly expected to delay consideration of legislation focused on addressing the opioid crisis until after the elections.Opioid legislation stalls in Senate following House approval of bills in June
- As other priorities loom and the legislative calendar tightens, Senate could delay consideration of opioid bill until after midterm elections.
- As Congress considers next steps on opioid legislation, NACo is engaging with key lawmakers to ensure counties have necessary resources to combat addiction in our communities.
July 31, 2018July 31, 2018, 2:00 pm
-
Blog
Opioid legislation stalls in Senate following House approval of bills in June
As the November midterm elections draw closer, the U.S. Senate is increasingly expected to delay consideration of legislation focused on addressing the opioid crisis until after the elections. This impasse follows significant movement in both chambers and the passage of comprehensive opioid legislation in the U.S. House of Representatives in June.
The Senate’s delay comes after members spent the first several months of the year considering dozens of opioid bills across various committees, some of which were included in the wide-ranging Opioid Crisis Response Act (S. 2680) approved in May by the Senate Health, Education, Labor and Pensions (HELP) Committee.
As Congress considers bills supporting the nation’s response to the opioid epidemic, NACo is engaging with legislators to ensure counties have the resources to address the addiction crisis in our communities. Of the Senate bills under consideration, NACo endorsed the Comprehensive Addiction Resources Emergency (CARE) Act (S. 2700/H.R. 5545), which would make direct investments in state and local agencies operating on the frontlines of the epidemic, including emergency first responders, public health departments and regional epidemiology centers.
Looking ahead, the Senate’s path forward is complicated by the chamber’s busy legislative calendar over the next three months. While the House has adjourned for the annual August recess, the Senate will remain in session for most of the month, but is expected to focus on FY 2019 appropriations, major program reauthorizations and presidential judicial appointments. Members of Congress are also expected to return home for the month leading up to midterm elections, leaving limited time in the months ahead for legislators to negotiate next steps on opioid proposals.
The Senate had been expected to build on the momentum from the House, where legislators moved quickly throughout May and June to combine 58 narrowly-focused opioid proposals into the SUPPORT for Patients and Communities Act (H.R. 6). Throughout the spring, as House members worked toward passage of their legislative package, NACo advocated for provisions that would streamline delivery of addiction treatment services for youth and improve access to behavioral health information technology for medical providers, among others. Several of these proposals were ultimately included in H.R. 6.
As the November midterm elections draw closer, the U.S. Senate is increasingly expected to delay consideration of legislation focused on addressing the opioid crisis until after the elections.2018-07-31Blog2018-11-26
As the November midterm elections draw closer, the U.S. Senate is increasingly expected to delay consideration of legislation focused on addressing the opioid crisis until after the elections. This impasse follows significant movement in both chambers and the passage of comprehensive opioid legislation in the U.S. House of Representatives in June.
The Senate’s delay comes after members spent the first several months of the year considering dozens of opioid bills across various committees, some of which were included in the wide-ranging Opioid Crisis Response Act (S. 2680) approved in May by the Senate Health, Education, Labor and Pensions (HELP) Committee.
As Congress considers bills supporting the nation’s response to the opioid epidemic, NACo is engaging with legislators to ensure counties have the resources to address the addiction crisis in our communities. Of the Senate bills under consideration, NACo endorsed the Comprehensive Addiction Resources Emergency (CARE) Act (S. 2700/H.R. 5545), which would make direct investments in state and local agencies operating on the frontlines of the epidemic, including emergency first responders, public health departments and regional epidemiology centers.
Looking ahead, the Senate’s path forward is complicated by the chamber’s busy legislative calendar over the next three months. While the House has adjourned for the annual August recess, the Senate will remain in session for most of the month, but is expected to focus on FY 2019 appropriations, major program reauthorizations and presidential judicial appointments. Members of Congress are also expected to return home for the month leading up to midterm elections, leaving limited time in the months ahead for legislators to negotiate next steps on opioid proposals.
The Senate had been expected to build on the momentum from the House, where legislators moved quickly throughout May and June to combine 58 narrowly-focused opioid proposals into the SUPPORT for Patients and Communities Act (H.R. 6). Throughout the spring, as House members worked toward passage of their legislative package, NACo advocated for provisions that would streamline delivery of addiction treatment services for youth and improve access to behavioral health information technology for medical providers, among others. Several of these proposals were ultimately included in H.R. 6.

-
Blog
Recent federal action advances key maternal health policies
On December 23, 2022, Congress passed the Fiscal Year (FY) 2023 omnibus appropriations bill, which included a provision that would permanently grant states the option to provide 12 months of Medicaid coverage for postpartum women and children – a key win for counties. -
Blog
New federal guidance improves access to opioid treatment in county jails
Two new reports from the Office of National Drug Control Policy (ONDCP) and U.S. Department of Justice (DOJ) offer guidance on improving the provision of medication-assisted treatment (MAT) for opioid use disorders (OUD) in correctional facilities as well as clarifies disability protections of people on MAT for OUD. -
Blog
SAMHSA releases new survey data on rates of mental illness and substance use disorder in the U.S.
On January 4, the U.S. -
Reports & Toolkits
Legislative Analysis for Counties: The Consolidated Appropriations Act of 2023
This analysis includes funding highlights for key programs impacting counties. -
County Profiles
Counties in Action
Learn how counties are demonstrating leadership and commitment to delivering effective abatement activities at the local level. -
Webinar
Reducing Jail Populations: Decreasing Pretrial Length of Stay by Improving Court Proceedings and Pretrial Services and Supervision
Jan. 5, 2023 , 2:00 pm – 3:00 pmUnable to attend? Watch the recording here.
Related Posts
-
County NewsHamilton County, Ohio creates ‘Safe Sleep’ Initiative to prevent infant deathsJan. 30, 2023
-
BlogWhat have we learned about governing during the pandemic era?Jan. 27, 2023
-
BlogRecent federal action advances key maternal health policiesJan. 19, 2023
Related Resources
-
Reports & ToolkitsCounty Funding Opportunities to Support Community Members Experiencing a Behavioral Health CrisisFeb. 8, 2023
-
Reports & ToolkitsMedication-Assisted Treatment (“MAT”) for Opioid Use DisorderFeb. 6, 2023
-
Policy BriefEnhance Counties' Ability to Prevent and Treat Mental Illness and Substance Use DisordersFeb. 1, 2023
Related Events
-
8Feb2023Webinar
Local Strategies for Reaching Families and Young Children Experiencing Homelessness
Feb. 8, 2023 , 2:00 pm – 3:00 pm
More From
-
Opioid Solutions Center
NACo’s Opioid Solutions Center empowers local leaders to invest resources in effective treatment, recovery, prevention and harm reduction practices that save lives and address the underlying causes of substance use disorder.
Learn More